top of page
Background_edited_edited.jpg

Vijay Padul, Phd

Sr. Scientist – Omics

Vijay Padul is a Senior Scientist at Rhenix, where he leads bioinformatics, genomics, and Next Generation Sequencing research-related activities, in the organization. He is currently working on the neoantigen cancer vaccine pipeline projects.

​

Vijay holds a Ph.D. in Life Sciences from TMC-ACTREC, Homi Bhabha National Institute, Navi Mumbai. His Ph.D. study focused on Cancer Genomics. Previously, Vijay has worked as an Assistant Professor at graduate and post-graduate degree colleges as well.

At Rhenix, he has gained experience in scientific, operational, and administrative matters.

Stories

Summary "A phase Ib-IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma- CUSP9v3-2021"

Glioblastoma is the most common and aggressive primary malignant brain tumor in adults. Despite therapeutic interventions, glioblastoma prognosis remains very poor as most patients die…

Glioblastoma Multiforme - VP.jpg

Summary "Uncovering the link between chromatin activity, gene expression in myeloid cells, and Alzheimer’s disease risk."

Alzheimer’s disease (AD) is a progressive neurological disorder commonly affecting people older than 65 years of age. The neurodegenerative progression of the disorder causes...

Alzheimer's disease.jpg

Summary "An effective integrated grading system for meningioma tumor grading that incorporates molecular features."

Meningioma is the most common primary intracranial tumor in the United States. There are approximately 35,000 new cases diagnosed every year. meningioma has an estimated population prevalence of approximately...

Meningioma

Summary "Multi-omic analysis of low-grade glioma histological subtypes uncovers the significance of tumor purity."

Astrocytoma and Oligodendroglioma are the histological subtypes of glioma brain tumors. Histological classification of gliomas has been the clinical practice before the inclusion of molecular markers by the...

Astrocytoma.jpg

Summary "Nivolumab therapy in addition to chemotherapy improves survival in patients with resectable lung cancer."

Lung cancer is the third most common cancer in the United States. Over 80% of the total lung cancer cases belong to the type of non-small cell lung cancer (NSCLC). Among the patients diagnosed with...

Resectable Lung Cancer.jpg

Summary "A multicenter study uncovers genetic factors that may play a significant role in mice longevity."

Aging is a yet to be fully understood process where molecular, cellular, and organismal homeostasis is affected by multiple environmental and genetic factors which results in a progressive functional decline in physical...

Genetic factors of longevity

Summary "Genomics: Can it answer longevity questions?"

Historically the attainment of healthy human longevity has remained a distant dream. With the advent of whole genome sequencing technology an entire genetic blueprint of the human can be elucidated in a short...

Genomics and longevity

Summary "Health informatics: Health and genetics data to predict longevity."

The desire to live a healthy long life has been a constant drive in search of solutions to achieve human longevity. With the advancement in medical science, successful treatment, and management of a large number...

Summary "Inherited components of longevity."

Aging and longevity have a strong genetic component. Every living organism is born with a set of genetic material that constitutes its genome. Humans inherit their genomes and associated genetic traits from their parents.

Summary "A multi-omic study identifies high confidence genes implicated in biological aging."

Aging-related degenerative diseases are the leading cause of death in developed nations. Current medical interventions are aimed at delaying the onset or treating the symptoms of individual age-related...

Summary "Trial of the MIND diet for prevention of cognitive decline in older persons."

Age-related cognitive decline is a major health and lifestyle issue in older people. Cognitive decline and associated functional incapability increase the burden on healthcare delivery by caregivers and family members. There is...

Videos

A phase Ib-IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma- CUSP9v3-2021 | Cell talk

Glioblastoma is the most common and most aggressive primary malignant brain tumor in adults. Despite therapeutic interventions, the glioblastoma prognosis remains very poor as most patients die within 12 months after diagnosis...

Uncovering the link between chromatin activity, gene expression in myeloid cells, and Alzheimer’s disease risk | Cell talk

Alzheimer’s disease (AD) is a progressive neurological disorder commonly affecting people older than 65 years of age. The neurodegenerative progression of the disorder causes the death of the brain cells which results in brain atrophy...

An effective integrated grading system for meningioma tumor grading that incorporates molecular features | Cell talk

Meningioma is the most common primary intracranial tumor in the United States. There are approximately 35,000 new cases diagnosed every year. meningioma has an estimated population prevalence of approximately 1 in every...

Multi-omic analysis of low-grade glioma histological subtypes uncovers the significance of tumor purity | Cell talk

Astrocytoma and Oligodendroglioma are the histological subtypes of glioma brain tumors. Histological classification of gliomas has been the clinical practice before the inclusion of molecular markers by the World Health Organization (WHO) Classification...

Nivolumab therapy in addition to chemotherapy improves survival in patients with resectable lung cancer | Cell talk

Lung cancer is the third most common cancer in the United States. Over 80% of the total lung cancer cases belong to the type of non-small cell lung cancer (NSCLC). Among the patients diagnosed with NSCLC, ~20 to 25% have resectable cancer. Patients with...

A multicenter study uncovers genetic factors that may play a significant role in mice longevity | Cell talk

Aging is a yet to be fully understood process where molecular, cellular, and organismal homeostasis is affected by multiple environmental and genetic factors which results in a progressive functional decline in physical, mental, and reproductive...

Genomics: Can it answer longevity questions | Cell talk

Historically the attainment of healthy human longevity has remained a distant dream. With the advent of whole genome sequencing technology, an entire genetic blueprint of the human can be elucidated in a short time. The increased resolution...

Health informatics: Health and genetics data to predict longevity | Cell talk

The desire to live a healthy long life has been a constant drive in search of solutions to achieve human longevity. With the advancement in medical science, successful treatment, and management of a large number of diseases has become...

Inherited components of longevity | Cell talk

Aging and longevity has a strong genetic component. Every living organism is born with a set of genetic material that constitutes its genome. Humans inherit their genome and associated genetic traits from their parents.

A multi-omic study identifies high confidence genes implicated in biological aging | Cell talk

Aging-related degenerative diseases are the leading cause of death in developed nations. Current medical interventions are aimed at delaying the onset or treating the symptoms of individual age-related diseases. Alternative approach...

Trial of the MIND diet for prevention of cognitive decline in older persons | Cell talk

Age-related cognitive decline is a major health and lifestyle issue in older people. Cognitive decline and associated functional incapability increase the burden on healthcare delivery by caregivers and family members. There is a need to identify...

Background_edited_edited.jpg

Get the latest updates

Join Cell talk!

Subscribe to us today and receive the latest updates in your mailbox!

bottom of page